KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Equity (2018 - 2026)

Aquestive Therapeutics has reported Return on Equity over the past 8 years, most recently at 0.04% for Q4 2025.

  • For Q4 2025, Return on Equity rose 4.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, up 4.0%, while the annual FY2025 figure was 0.02%, 1.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.04% at Aquestive Therapeutics, up from 0.02% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.04% in Q4 2025 and troughed at 0.0% in Q4 2023.
  • A 5-year average of 0.01% and a median of 0.01% in 2022 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: fell -4bps in 2021 and later increased 4bps in 2025.
  • Year by year, Return on Equity stood at 0.01% in 2021, then tumbled by -51bps to 0.0% in 2022, then plummeted by -84bps to 0.0% in 2023, then soared by 1012bps to 0.01% in 2024, then skyrocketed by 431bps to 0.04% in 2025.
  • Business Quant data shows Return on Equity for AQST at 0.04% in Q4 2025, 0.02% in Q3 2025, and 0.01% in Q2 2025.